Related references
Note: Only part of the references are listed.BACE1 inhibitors: Current status and future directions in treating Alzheimer's disease
Nour M. Moussa-Pacha et al.
MEDICINAL RESEARCH REVIEWS (2020)
A systematic review and meta-analysis of rTMS effects on cognitive enhancement in mild cognitive impairment and Alzheimer's disease
Ying-hui Chou et al.
NEUROBIOLOGY OF AGING (2020)
Effects of a combined transcranial magnetic stimulation (TMS) and cognitive training intervention in patients with Alzheimer's disease
Marwan Sabbagh et al.
ALZHEIMERS & DEMENTIA (2020)
Breakdown of spatial coding and interneuron synchronization in epileptic mice
Tristan Shuman et al.
NATURE NEUROSCIENCE (2020)
Filamin A inhibition reduces seizure activity in a mouse model of focal cortical malformations
Longbo Zhang et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
LTP-like cortical plasticity predicts conversion to dementia in patients with memory impairment
Francesco Di Lorenzo et al.
BRAIN STIMULATION (2020)
Neurophysiological signatures in Alzheimer's disease are distinctly associated with TAU, amyloid-β accumulation, and cognitive decline
Kamalini G. Ranasinghe et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
GSK3β and Tau Protein in Alzheimer's Disease and Epilepsy
Danira Toral-Rios et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2020)
Are ketogenic diets promising for Alzheimer's disease? A translational review
Matthieu Lilamand et al.
ALZHEIMERS RESEARCH & THERAPY (2020)
Long-term safety and tolerability of atabecestat (JNJ-54861911), an oral BACE1 inhibitor, in early Alzheimer's disease spectrum patients: a randomized, double-blind, placebo-controlled study and a two-period extension study
Gerald Novak et al.
ALZHEIMERS RESEARCH & THERAPY (2020)
Partial reduction of amyloid β production by β-secretase inhibitors does not decrease synaptic transmission
Tugce Munise Satir et al.
ALZHEIMERS RESEARCH & THERAPY (2020)
Biomaterials to Neuroprotect the Stroke Brain: A Large Opportunity for Narrow Time Windows
Daniel Gonzalez-Nieto et al.
CELLS (2020)
Consequences of hyperphosphorylated tau on the morphology and excitability of hippocampal neurons in aged tau transgenic mice
Lennart Mueller-Thomsen et al.
NEUROBIOLOGY OF AGING (2020)
Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia A Randomized Clinical Trial
Suzanne Craft et al.
JAMA NEUROLOGY (2020)
GABAergic Inhibitory Interneuron Deficits in Alzheimer's Disease: Implications for Treatment
Yilan Xu et al.
FRONTIERS IN NEUROSCIENCE (2020)
Synergy between amyloid-β and tau in Alzheimer's disease
Marc Aurel Busche et al.
NATURE NEUROSCIENCE (2020)
Tipping the Scales: Peptide-Dependent Dysregulation of Neural Circuit Dynamics in Alzheimer's Disease
Samuel S. Harris et al.
NEURON (2020)
The impact of lacosamide on mood disorders in adult patients with epilepsy: A systematic review
Sofia Toniolo et al.
EPILEPSY & BEHAVIOR (2020)
Individually customized transcranial temporal interference stimulation for focused modulation of deep brain structures: a simulation study with different head models
Sangjun Lee et al.
SCIENTIFIC REPORTS (2020)
Translating genetic risk of Alzheimer's disease into mechanistic insight and drug targets
Annerieke Sierksma et al.
SCIENCE (2020)
PTI-125 Reduces Biomarkers of Alzheimer's Disease in Patients
H-Y Wang et al.
JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE (2020)
TRanscranial AlterNating current Stimulation FOR patients with Mild Alzheimer's Disease (TRANSFORM-AD study): Protocol for a randomized controlled clinical trial
Yi Xing et al.
ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2020)
Alzheimer's disease and late-onset epilepsy of unknown origin: two faces of beta amyloid pathology
Cinzia Costa et al.
NEUROBIOLOGY OF AGING (2019)
In vivo imaging reveals reduced activity of neuronal circuits in a mouse tauopathy model
Petar Marinkovic et al.
BRAIN (2019)
Multi-sensory Gamma Stimulation Ameliorates Alzheimer's-Associated Pathology and Improves Cognition
Anthony J. Martorell et al.
CELL (2019)
Sleep oscillation-specific associations with Alzheimer's disease CSF biomarkers: novel roles for sleep spindles and tau
Korey Kam et al.
MOLECULAR NEURODEGENERATION (2019)
Functional networks are impaired by elevated tau-protein but reversible in a regulatable Alzheimer's disease mouse model
Claudia Green et al.
MOLECULAR NEURODEGENERATION (2019)
Comparative neuropsychological effects of carbamazepine and eslicarbazepine acetate
Kimford J. Meador et al.
EPILEPSY & BEHAVIOR (2019)
In Vivo Synaptic Density Imaging with 11C-UCB-J Detects Treatment Effects of Saracatinib in a Mouse Model of Alzheimer Disease
Takuya Toyonaga et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Gamma Entrainment Binds Higher-Order Brain Regions and Offers Neuroprotection
Chinnakkaruppan Adaikkan et al.
NEURON (2019)
Preliminary Results of a Trial of Atabecestat in Preclinical Alzheimer's Disease
David Henley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
The overlap between epilepsy and Alzheimer's disease and the consequences for treatment
Graham Powell et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2019)
Effect of AZD0530 on Cerebral Metabolic Decline in Alzheimer Disease A Randomized Clinical Trial
Christopher H. van Dyck et al.
JAMA NEUROLOGY (2019)
Ketogenic Diet in Alzheimer's Disease
Marta Rusek et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Loss of tau and Fyn reduces compensatory effects of MAP2 for tau and reveals a Fyn-independent effect of tau on calcium
Guanghao Liu et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2019)
A vicious cycle of β amyloid-dependent neuronal hyperactivation
Benedikt Zott et al.
SCIENCE (2019)
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
Justin M. Long et al.
CELL (2019)
Antidiabetic medication and risk of dementia in patients with type 2 diabetes: a nested case control study
Ida Kim Wium-Andersen et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2019)
A Clinical Trial of Transcranial Electromagnetic Treatment in Alzheimer's Disease: Cognitive Enhancement and Associated Changes in Cerebrospinal Fluid, Blood, and Brain Imaging
Gary Arendash et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
The prevalence and clinical features of epileptic seizures in a memory clinic population
John Baker et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2019)
Identification of GSK-3 as a Potential Therapeutic Entry Point for Epilepsy
Najat Aourz et al.
ACS CHEMICAL NEUROSCIENCE (2019)
Mechanisms of hyperexcitability in Alzheimer's disease hiPSC-derived neurons and cerebral organoids vs isogenic controls
Swagata Ghatak et al.
ELIFE (2019)
LTP-like cortical plasticity is associated with verbal memory impairment in Alzheimer's disease patients
Francesco Di Lorenzo et al.
BRAIN STIMULATION (2019)
Gabapentin and pregabalin to treat aggressivity in dementia: a systematic review and illustrative case report
Thitiporn Supasitthumrong et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Characterizing hippocampal dynamics with MEG: A systematic review and evidence-based guidelines
Emily Ruzich et al.
HUMAN BRAIN MAPPING (2019)
Targeted delivery of intranasally administered nanoparticles-mediated neuroprotective peptide NR2B9c to brain and neuron for treatment of ischemic stroke
Rui Li et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2019)
Tau impairs neural circuits, dominating amyloid-beta effects, in Alzheimer models in vivo
Marc Aurel Busche et al.
NATURE NEUROSCIENCE (2019)
Secreted amyloid-β precursor protein functions as a GABABR1a ligand to modulate synaptic transmission
Heather C. Rice et al.
SCIENCE (2019)
Reduced non-rapid eye movement sleep is associated with tau pathology in early Alzheimer's disease
Brendan P. Lucey et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Amyloid Beta and Tau Cooperate to Cause Reversible Behavioral and Transcriptional Deficits in a Model of Alzheimer's Disease
Eleanor K. Pickett et al.
CELL REPORTS (2019)
Effects of Home Photobiomodulation Treatments on Cognitive and Behavioral Function, Cerebral Perfusion, and Resting-State Functional Connectivity in Patients with Dementia: A Pilot Trial
Linda L. Chao
PHOTOBIOMODULATION PHOTOMEDICINE AND LASER SURGERY (2019)
Therapeutic Role of Transcranial Direct Current Stimulation in Alzheimer Disease Patients: Double-Blind, Placebo-Controlled Clinical Trial
Eman M. Khedr et al.
NEUROREHABILITATION AND NEURAL REPAIR (2019)
History and progress of hypotheses and clinical trials for Alzheimer's disease
Pei-Pei Liu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2019)
Neurophysiological Markers of Alzheimer's Disease: Quantitative EEG Approach
Una Smailovic et al.
NEUROLOGY AND THERAPY (2019)
Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer's Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial
Gordon K. Wilcock et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Seizures in Alzheimer's disease: is there more beneath the surface?
Marc Edwards et al.
JOURNAL OF NEUROLOGY (2018)
Lacosamide in the Management of Behavioral Symptoms in Frontotemporal Dementia A 2-Case Report
Francesco Di Lorenzo et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2018)
Targeting Fyn Kinase in Alzheimer's Disease
Haakon B. Nygaard
BIOLOGICAL PSYCHIATRY (2018)
Electromagnetic signatures of the preclinical and prodromal stages of Alzheimer's disease
Akinori Nakamura et al.
BRAIN (2018)
Cognition and dementia in older patients with epilepsy
Arjune Sen et al.
BRAIN (2018)
Contribution of early Alzheimer's disease-related pathophysiology to the development of acquired epilepsy
Tilo Gschwind et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2018)
Changes in regional cerebral blood flow associated with a 45 day course of the ketogenic agent, caprylidene, in patients with mild to moderate Alzheimer's disease: Results of a randomized, double-blinded, pilot study
Nare Torosyan et al.
EXPERIMENTAL GERONTOLOGY (2018)
Pharmacotherapeutic strategies for treating epilepsy in patients with Alzheimer's disease
Benjamin Cretin
EXPERT OPINION ON PHARMACOTHERAPY (2018)
Autotaxin-Lysophosphatidic Acid Signaling in Alzheimer's Disease
Sindhu Ramesh et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Synaptic phospholipids as a new target for cortical hyperexcitability and E/I balance in psychiatric disorders
Carine Thalman et al.
MOLECULAR PSYCHIATRY (2018)
Tau-targeting therapies for Alzheimer disease
Erin E. Congdon et al.
NATURE REVIEWS NEUROLOGY (2018)
Transcranial magnetic stimulation of the precuneus enhances memory and neural activity in prodromal Alzheimer's disease
Giacomo Koch et al.
NEUROIMAGE (2018)
Glutamatergic synaptic plasticity and dysfunction in Alzheimer disease Emerging mechanisms
Eduardo E. Benarroch
NEUROLOGY (2018)
Nav1.1-Overexpressing Interneuron Transplants Restore Brain Rhythms and Cognition in a MouseModel of Alzheimer's Disease
Magdalena Martinez-Losa et al.
NEURON (2018)
Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer's Disease
Michael F. Egan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
AAVrh.10-Mediated APOE2 Central Nervous System Gene Therapy for APOE4-Associated Alzheimer's Disease
Jonathan B. Rosenberg et al.
HUMAN GENE THERAPY CLINICAL DEVELOPMENT (2018)
An exploratory clinical study of p38 kinase inhibition in Alzheimer's disease
Philip Scheltens et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2018)
Brain Stimulation in Alzheimer's Disease
Chun-Hung Chang et al.
FRONTIERS IN PSYCHIATRY (2018)
A Comprehensive Review of Magnetoencephalography (MEG) Studies for Brain Functionality in Healthy Aging and Alzheimer's Disease (AD)
Pravat K. Mandal et al.
FRONTIERS IN COMPUTATIONAL NEUROSCIENCE (2018)
Riluzole reduces amyloid beta pathology, improves memory, and restores gene expression changes in a transgenic mouse model of early-onset Alzheimer's disease
Masahir Okamoto et al.
TRANSLATIONAL PSYCHIATRY (2018)
Neurostimulation Combined With Cognitive Intervention in Alzheimer's Disease (NeuroAD): Study Protocol of Double-Blind, Randomized, Factorial Clinical Trial
Suellen Marinho Andrade et al.
FRONTIERS IN AGING NEUROSCIENCE (2018)
Antisense oligonucleotides in neurological disorders
Claudia D. Wurster et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2018)
Ketogenic diets for drug-resistant epilepsy
Kirsty J. Martin-McGill et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2018)
A review of the pharmacology and clinical efficacy of brivaracetam
Pavel Klein et al.
CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS (2018)
Effects of adjunctive perampanel on sleep quality, daytime somnolence and cognition in refractory focal epilepsy: Further data. Author's response
Manuel Toledo
EPILEPSY & BEHAVIOR (2017)
Association Between Midlife Vascular Risk Factors and Estimated Brain Amyloid Deposition
Rebecca F. Gottesman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Adult-Onset Epilepsy in Presymptomatic Alzheimer's Disease: A Retrospective Study
Jacopo C. DiFrancesco et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Autotaxin is Related to Metabolic Dysfunction and Predicts Alzheimer's Disease Outcomes
Kelsey E. McLimans et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Effects of Regular and Long-Acting Insulin on Cognition and Alzheimer's Disease Biomarkers: A Pilot Clinical Trial
Suzanne Craft et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Role of Glutamate and NMDA Receptors in Alzheimer's Disease
Rui Wang et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Epileptic activity in Alzheimer's disease: causes and clinical relevance
Keith A. Vossel et al.
LANCET NEUROLOGY (2017)
Silent hippocampal seizures and spikes identified by foramen ovale electrodes in Alzheimer's disease
Alice D. Lam et al.
NATURE MEDICINE (2017)
Generation of pure GABAergic neurons by transcription factor programming
Nan Yang et al.
NATURE METHODS (2017)
PTI-125 binds and reverses an altered conformation of filamin A to reduce Alzheimer's disease pathogenesis (Publication with Expression of Concern. See vol. 113, pg. 152, 2022)
Hoau-Yan Wang et al.
NEUROBIOLOGY OF AGING (2017)
Effect of topiramate and zonisamide on fMRI cognitive networks
Britta Wandschneider et al.
NEUROLOGY (2017)
Antisense Oligonucleotides: Translation from Mouse Models to Human Neurodegenerative Diseases
Kathleen M. Schoch et al.
NEURON (2017)
Tau Pathology Induces Excitatory Neuron Loss, Grid Cell Dysfunction, and Spatial Memory Deficits Reminiscent of Early Alzheimer's Disease
Hongjun Fu et al.
NEURON (2017)
Optogenetic Restoration of Disrupted Slow Oscillations Halts Amyloid Deposition and Restores Calcium Homeostasis in an Animal Model of Alzheimer's Disease
Ksenia V. Kastanenka et al.
PLOS ONE (2017)
BACE inhibition-dependent repair of Alzheimer's pathophysiology
Aylin D. Keskin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Tolerability of lacosamide or zonisamide in elderly patients with seizures
Rani A. Sarkis et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2017)
SGLT2-inhibitor and DPP-4 inhibitor improve brain function via attenuating mitochondrial dysfunction, insulin resistance, inflammation, and apoptosis in HFD-induced obese rats
Piangkwan Sa-nguanmoo et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2017)
Eslicarbazepine Acetate: A New Improvement on a Classic Drug Family for the Treatment of Partial-Onset Seizures
Graciana L. Galiana et al.
DRUGS IN R&D (2017)
Neuronal hyperactivity due to loss of inhibitory tone in APOE4 mice lacking Alzheimer's disease-like pathology
Tal Nuriel et al.
NATURE COMMUNICATIONS (2017)
Hippocampal activation is associated with longitudinal amyloid accumulation and cognitive decline
Stephanie L. Leal et al.
ELIFE (2017)
Association Between Childhood-Onset Epilepsy and Amyloid Burden 5 Decades Later
Juho Joutsa et al.
JAMA NEUROLOGY (2017)
Differential contribution of APP metabolites to early cognitive deficits in a TgCRND8 mouse model of Alzheimer's disease
Valentine Hamm et al.
SCIENCE ADVANCES (2017)
The Fall of Sleep K-Complex in Alzheimer Disease
Luigi De Gennaro et al.
SCIENTIFIC REPORTS (2017)
Targeting Neuroinflammation to Treat Alzheimer's Disease
A. Ardura-Fabregat et al.
CNS DRUGS (2017)
Interictal epileptiform activity outside the seizure onset zone impacts cognition
Hoameng Ung et al.
BRAIN (2017)
Noninvasive Deep Brain Stimulation via Temporally Interfering Electric Fields
Nir Grossman et al.
CELL (2017)
Hyperphosphorylated tau causes reduced hippocampal CA1 excitability by relocating the axon initial segment
Robert John Hatch et al.
ACTA NEUROPATHOLOGICA (2017)
Clinical Effects of Tramiprosate in APOE4/4 Homozygous Patients with Mild Alzheimer's Disease Suggest Disease Modification Potential
S. Abushakra et al.
JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE (2017)
Incidence and Impact of Subclinical Epileptiform Activity in Alzheimer's Disease
Keith A. Vossel et al.
ANNALS OF NEUROLOGY (2016)
Long-Term Potentiation-Like Cortical Plasticity Is Disrupted in Alzheimer's Disease Patients Independently from Age of Onset
Francesco Di Lorenzo et al.
ANNALS OF NEUROLOGY (2016)
Alzheimer's Disease Mechanisms and Emerging Roads to Novel Therapeutics
Carlo Sala Frigerio et al.
ANNUAL REVIEW OF NEUROSCIENCE, VOL 39 (2016)
Hyperphosphorylated tau in patients with refractory epilepsy correlates with cognitive decline: a study of temporal lobe resections
Xin You Tai et al.
BRAIN (2016)
Alzheimer's Disease Genetic Risk Factor APOE-ε4 Also Affects Normal Brain Function
Amanda M. DiBattista et al.
CURRENT ALZHEIMER RESEARCH (2016)
Cognitive effects of adjunctive perampanel for partial-onset seizures: A randomized trial
Kimford J. Meador et al.
EPILEPSIA (2016)
Regional and global connectivity disturbances in focal epilepsy, related neurocognitive sequelae, and potential mechanistic underpinnings
Dario J. Englot et al.
EPILEPSIA (2016)
The effects of lacosamide on cognition, quality-of-life measures, and quality of life in patients with refractory partial epilepsy
Marcelo E. Lancman et al.
EPILEPSY & BEHAVIOR (2016)
Randomized double-blind comparison of cognitive and EEG effects of lacosamide and carbamazepine
Kimford J. Meador et al.
EPILEPSY & BEHAVIOR (2016)
Sensorimotor Cortex Excitability and Connectivity in Alzheimer's Disease: A TMS-EEG Co-Registration Study
Florinda Ferreri et al.
HUMAN BRAIN MAPPING (2016)
Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial
Serge Gauthier et al.
LANCET (2016)
Gamma frequency entrainment attenuates amyloid load and modifies microglia
Hannah F. Iaccarino et al.
NATURE (2016)
The antibody aducanumab reduces Aβ plaques in Alzheimer's disease
Jeff Sevigny et al.
NATURE (2016)
Interictal epileptiform discharges induce hippocampal-cortical coupling in temporal lobe epilepsy
Jennifer N. Gelinas et al.
NATURE MEDICINE (2016)
Neuronal activity enhances tau propagation and tau pathology in vivo
Jessica W. Wu et al.
NATURE NEUROSCIENCE (2016)
DESIGN OF THE PHASE II CLINICAL STUDY OF THE TAU VACCINE AADVAC1 IN PATIENTS WITH MILD ALZHEIMER'S DISEASE
Matej Ondrus et al.
NEUROBIOLOGY OF AGING (2016)
Intracerebral adeno-associated virus gene delivery of apolipoprotein E2 markedly reduces brain amyloid pathology in Alzheimer's disease mouse models
Lingzhi Zhao et al.
NEUROBIOLOGY OF AGING (2016)
Impairments of neural circuit function in Alzheimer's disease
Marc Aurel Busche et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2016)
Transcranial direct current stimulation as a memory enhancer in patients with Alzheimer's disease: a randomized, placebo-controlled trial
Martin Bystad et al.
ALZHEIMERS RESEARCH & THERAPY (2016)
Bapineuzumab for mild to moderate Alzheimer's disease in two global, randomized, phase 3 trials
Rik Vandenberghe et al.
ALZHEIMERS RESEARCH & THERAPY (2016)
Alpha band disruption in the AD-continuum starts in the Subjective Cognitive Decline stage: a MEG study
D. Lopez-Sanz et al.
SCIENTIFIC REPORTS (2016)
Fyn inhibition rescues established memory and synapse loss in Alzheimer mice
Adam C. Kaufman et al.
ANNALS OF NEUROLOGY (2015)
Neuronal hyperactivity - A key defect in Alzheimer's disease?
Marc Aurel Busche et al.
BIOESSAYS (2015)
Amyloid-β deposition in mild cognitive impairment is associated with increased hippocampal activity, atrophy and clinical progression
Willem Huijbers et al.
BRAIN (2015)
Childhood-onset epilepsy five decades later. A prospective population-based cohort study
Matti Sillanpaa et al.
EPILEPSIA (2015)
Use of Benzodiazepines in Alzheimer's Disease: A Systematic Review of Literature
Michaela Defrancesco et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2015)
An Increased Risk of Reversible Dementia May Occur After Zolpidem Derivative Use in the Elderly Population A Population-Based Case-Control Study
Hsin-I Shih et al.
MEDICINE (2015)
Rescue of long-range circuit dysfunction in Alzheimer's disease models
Marc Aurel Busche et al.
NATURE NEUROSCIENCE (2015)
Glutamate presynaptic vesicular transporter and postsynaptic receptor levels correlate with spatial memory status in aging rat models
Caroline Menard et al.
NEUROBIOLOGY OF AGING (2015)
Pathological Tau Disrupts Ongoing Network Activity
Noa Menkes-Caspi et al.
NEURON (2015)
Reduced grid-cell-like representations in adults at genetic risk for Alzheimer's disease
Lukas Kunz et al.
SCIENCE (2015)
Brivaracetam, but not ethosuximide, reverses memory impairments in an Alzheimer's disease mouse model
Haakon B. Nygaard et al.
ALZHEIMERS RESEARCH & THERAPY (2015)
Chronic Glutamate Toxicity in Neurodegenerative Diseases-What is the Evidence?
Jan Lewerenz et al.
FRONTIERS IN NEUROSCIENCE (2015)
Response of the medial temporal lobe network in amnestic mild cognitive impairment to therapeutic intervention assessed by fMRI and memory task performance
Arnold Bakker et al.
NEUROIMAGE-CLINICAL (2015)
Phosphodiesterase-4 (PDE4) Molecular Pharmacology and Alzheimer's Disease
Mark E. Gurney et al.
NEUROTHERAPEUTICS (2015)
A Phase II Trial of Tideglusib in Alzheimer's Disease
Simon Lovestone et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Lithium as a Treatment for Alzheimer's Disease: A Systematic Review and Meta-Analysis
Shinji Matsunaga et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Stem cell therapy for Alzheimer's disease and related disorders: current status and future perspectives
Leslie M. Tong et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2015)
Cognitive impairment in epilepsy: the role of network abnormalities
Gregory L. Holmes
EPILEPTIC DISORDERS (2015)
Late-onset epilepsy and occult cerebrovascular disease
Lorna M. Gibson et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2014)
Intranasal therapeutic strategies for management of Alzheimer's disease
Sumeet Sood et al.
JOURNAL OF DRUG TARGETING (2014)
Inhibitory Interneuron Progenitor Transplantation Restores Normal Learning and Memory in ApoE4 Knock-In Mice without or with Aβ Accumulation
Leslie M. Tong et al.
JOURNAL OF NEUROSCIENCE (2014)
Anthocyanins restore behavioral and biochemical changes caused by streptozotocin-induced sporadic dementia of Alzheimer's type
Jessie M. Gutierres et al.
LIFE SCIENCES (2014)
GABA from reactive astrocytes impairs memory in mouse models of Alzheimer's disease
Seonmi Jo et al.
NATURE MEDICINE (2014)
Lamotrigine attenuates deficits in synaptic plasticity and accumulation of amyloid plaques in APP/PS1 transgenic mice
Mao-Ying Zhang et al.
NEUROBIOLOGY OF AGING (2014)
Seizure resistance without parkinsonism in aged mice after tau reduction
Zhiyong Li et al.
NEUROBIOLOGY OF AGING (2014)
Fyn kinase inhibition as a novel therapy for Alzheimer's disease
Haakon B. Nygaard et al.
ALZHEIMERS RESEARCH & THERAPY (2014)
Identification of structural determinants on tau protein essential for its pathological function: novel therapeutic target for tau immunotherapy in Alzheimer's disease
Eva Kontsekova et al.
ALZHEIMERS RESEARCH & THERAPY (2014)
A double-bling randomized clinical trail on the efficacy of cortical direct current stimulation for the treatment of Alzheimer's disease
Eman M. Khedr et al.
FRONTIERS IN AGING NEUROSCIENCE (2014)
Alzheimer's Disease and Stem Cell Therapy
Sung S. Choi et al.
Experimental Neurobiology (2014)
Animal models of epilepsy: use and limitations
Ludmyla Kandratavicius et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2014)
Network Dysfunction in Alzheimer's Disease: Refining the Disconnection Hypothesis
Matthew R. Brier et al.
BRAIN CONNECTIVITY (2014)
Lysophosphatidic acid induces increased BACE1 expression and A beta formation
Jing Shi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
Antiepileptics Topiramate and Levetiracetam Alleviate Behavioral Deficits and Reduce Neuropathology in APPswe/PS1dE9 Transgenic Mice
Jian-Quan Shi et al.
CNS NEUROSCIENCE & THERAPEUTICS (2013)
Amyloid β, Glutamate, Excitotoxicity in Alzheimer's Disease: Are We on the Right Track?
Zaira Esposito et al.
CNS NEUROSCIENCE & THERAPEUTICS (2013)
A Double-Blind, Placebo-Controlled, Ascending-Dose, Randomized Study to Evaluate the Safety, Tolerability and Effects on Cognition of AL-108 after 12 Weeks of Intranasal Administration in Subjects with Mild Cognitive Impairment
Bruce H. Morimoto et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2013)
Physiological release of endogenous tau is stimulated by neuronal activity
Amy M. Pooler et al.
EMBO REPORTS (2013)
Seizures in patients with Alzheimer's disease or vascular dementia: A population-based nested casecontrol analysis
Patrick Imfeld et al.
EPILEPSIA (2013)
Imaging the Interaction: Epileptic Discharges, Working Memory, and Behavior
Umair J. Chaudhary et al.
HUMAN BRAIN MAPPING (2013)
Treatment of Alzheimer's Disease with the GSK-3 Inhibitor Tideglusib: A Pilot Study
Teodoro del Ser et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
Presenilin-1 Mutations in Alzheimer's Disease: An Update on Genotype-Phenotype Relationships
A. J. Larner
JOURNAL OF ALZHEIMERS DISEASE (2013)
Antisense Reduction of Tau in Adult Mice Protects against Seizures
Sarah L. DeVos et al.
JOURNAL OF NEUROSCIENCE (2013)
Scaling Brain Size, Keeping Timing: Evolutionary Preservation of Brain Rhythms
Gyoergy Buzsaki et al.
NEURON (2013)
Anti-Tau Antibodies that Block Tau Aggregate Seeding In Vitro Markedly Decrease Pathology and Improve Cognition In Vivo
Kiran Yanamandra et al.
NEURON (2013)
A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease
Rachelle S. Doody et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Efficacy and Safety of A Liposome-Based Vaccine against Protein Tau, Assessed in Tau.P301L Mice That Model Tauopathy
Clara Theunis et al.
PLOS ONE (2013)
Seizures and Epileptiform Activity in the Early Stages of Alzheimer Disease
Keith A. Vossel et al.
JAMA NEUROLOGY (2013)
Epilepsy: neuroinflammation, neurodegeneration, and APOE genotype
Orwa Aboud et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2013)
Inhibitory Interneuron Deficit Links Altered Network Activity and Cognitive Dysfunction in Alzheimer Model
Laure Verret et al.
CELL (2012)
Synaptic and Extrasynaptic NMDA Receptors Are Gated by Different Endogenous Coagonists
Thomas Papouin et al.
CELL (2012)
PP2A and Alzheimer Disease
L. Torrent et al.
CURRENT ALZHEIMER RESEARCH (2012)
Insulin: An Emerging Treatment for Alzheimer's Disease Dementia?
Jill K. Morris et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2012)
GABA Attenuates Amyloid Toxicity by Downregulating its Endocytosis and Improves Cognitive Impairment
Xiaqin Sun et al.
JOURNAL OF ALZHEIMERS DISEASE (2012)
Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation
Scott A. Yuzwa et al.
NATURE CHEMICAL BIOLOGY (2012)
Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
Charles A. Dinarello et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Perampanel-new promise for refractory epilepsy?
Wolfgang Loescher et al.
NATURE REVIEWS NEUROLOGY (2012)
Reduction of Hippocampal Hyperactivity Improves Cognition in Amnestic Mild Cognitive Impairment
Arnold Bakker et al.
NEURON (2012)
Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model
Pascal E. Sanchez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Critical role of soluble amyloid-β for early hippocampal hyperactivity in a mouse model of Alzheimer's disease
Marc Aurel Busche et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Seizures in Alzheimer Disease: Clinical and Epidemiological Data
Dionysios Pandis et al.
EPILEPSY CURRENTS (2012)
Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease
Darin Jaturapatporn et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2012)
The potential protective effect of tramiprosate (homotaurine) against Alzheimer's disease: a review
Carlo Caltagirone et al.
AGING CLINICAL AND EXPERIMENTAL RESEARCH (2012)
Chronic Divalproex Sodium to Attenuate Agitation and Clinical Progression of Alzheimer Disease
Pierre N. Tariot et al.
ARCHIVES OF GENERAL PSYCHIATRY (2011)
Tramiprosate in mild-to-moderate Alzheimer's disease - a randomized, double-blind, placebo-controlled, multi-centre study (the Alphase Study)
Paul S. Aisen et al.
ARCHIVES OF MEDICAL SCIENCE (2011)
Amyloid β peptide oligomers directly activate NMDA receptors
Laura Texido et al.
CELL CALCIUM (2011)
Spontaneous epileptiform discharges in a mouse model of Alzheimer's disease are suppressed by antiepileptic drugs that block sodium channels
Sofya Ziyatdinova et al.
EPILEPSY RESEARCH (2011)
Long-Term Treatment with Lithium Alleviates Memory Deficits and Reduces Amyloid-beta Production in an Aged Alzheimer's Disease Transgenic Mouse Model
Xin Zhang et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
Transcranial magnetic stimulation in Alzheimer's disease: a neurophysiological marker of cortical hyperexcitability
Giovanni Pennisi et al.
JOURNAL OF NEURAL TRANSMISSION (2011)
Amyloid-β/Fyn-Induced Synaptic, Network, and Cognitive Impairments Depend on Tau Levels in Multiple Mouse Models of Alzheimer's Disease
Erik D. Roberson et al.
JOURNAL OF NEUROSCIENCE (2011)
Hippocampal Hyperactivation Associated with Cortical Thinning in Alzheimer's Disease Signature Regions in Non-Demented Elderly Adults
Deepti Putcha et al.
JOURNAL OF NEUROSCIENCE (2011)
Lysophosphatidic acid induces neurite retraction in differentiated neuroblastoma cells via GSK-3β activation
Yuanjie Sun et al.
MOLECULES AND CELLS (2011)
Neuronal activity regulates the regional vulnerability to amyloid-β deposition
Adam W. Bero et al.
NATURE NEUROSCIENCE (2011)
The role of inflammation in epilepsy
Annamaria Vezzani et al.
NATURE REVIEWS NEUROLOGY (2011)
Linking lipids to Alzheimer's disease: cholesterol and beyond
Gilbert Di Paolo et al.
NATURE REVIEWS NEUROSCIENCE (2011)
Protection against Aβ-mediated rapid disruption of synaptic plasticity and memory by memantine
Igor Klyubin et al.
NEUROBIOLOGY OF AGING (2011)
Chronic divalproex sodium use and brain atrophy in Alzheimer disease
A. S. Fleisher et al.
NEUROLOGY (2011)
Levetiracetam in the treatment of epilepsy
Bassel Abou-Khalil
Neuropsychiatric Disease and Treatment (2011)
Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial
Francois Piette et al.
ALZHEIMERS RESEARCH & THERAPY (2011)
GSK-3 inhibitors: preclinical and clinical focus on CNS
Hagit Eldar-Finkelman et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2011)
Levetiracetam: A Practical Option for Seizure Management in Elderly Patients With Cognitive Impairment
Carol F. Lippa et al.
AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS (2010)
Hippocampal Hyperactivation in Presymptomatic Familial Alzheimer's Disease
Yakeel T. Quiroz et al.
ANNALS OF NEUROLOGY (2010)
Heterogeneous neuronal firing patterns during interictal epileptiform discharges in the human cortex
Corey J. Keller et al.
BRAIN (2010)
Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models
Lars M. Ittner et al.
CELL (2010)
Levetiracetam, lamotrigine, and phenobarbital in patients with epileptic seizures and Alzheimer's disease
Eduardo Cumbo et al.
EPILEPSY & BEHAVIOR (2010)
Functional Connectivity in Mild Cognitive Impairment During a Memory Task: Implications for the Disconnection Hypothesis
Ricardo Bajo et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Apolipoprotein E4 Causes Age- and Tau-Dependent Impairment of GABAergic Interneurons, Leading to Learning and Memory Deficits in Mice
Yaisa Andrews-Zwilling et al.
JOURNAL OF NEUROSCIENCE (2010)
Amyloid β Induces the Morphological Neurodegenerative Triad of Spine Loss, Dendritic Simplification, and Neuritic Dystrophies through Calcineurin Activation
Hai-Yan Wu et al.
JOURNAL OF NEUROSCIENCE (2010)
BACE1-/- mice exhibit seizure activity that does not correlate with sodium channel level or axonal localization
Brian D. Hitt et al.
MOLECULAR NEURODEGENERATION (2010)
Amyloid-β-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks
Jorge J. Palop et al.
NATURE NEUROSCIENCE (2010)
Tau-knockout mice show reduced GSK3-induced hippocampal degeneration and learning deficits
Elena Gomez de Barreda et al.
NEUROBIOLOGY OF DISEASE (2010)
Exploratory, anxiety and spatial memory impairments are dissociated in mice lacking the LPA1 receptor
Estela Castilla-Ortega et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2010)
High-resolution structural and functional MRI of hippocampal CA3 and dentate gyrus in patients with amnestic Mild Cognitive Impairment
Michael A. Yassa et al.
NEUROIMAGE (2010)
Cognitive effects of pregabalin in healthy volunteers A double-blind, placebo-controlled trial
Martin Salinsky et al.
NEUROLOGY (2010)
Treatment Strategies Targeting Excess Hippocampal Activity Benefit Aged Rats with Cognitive Impairment
Ming Teng Koh et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Ethosuximide, Valproic Acid, and Lamotrigine in Childhood Absence Epilepsy.
Tracy A. Glauser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Epilepsy and Cognitive Impairments in Alzheimer Disease
Jorge J. Palop et al.
ARCHIVES OF NEUROLOGY (2009)
Antiepileptic Drug-Induced Cognitive Adverse Effects Potential Mechanisms and Contributing Factors
Marco Mula et al.
CNS DRUGS (2009)
Temporal cortex direct current stimulation enhances performance on a visual recognition memory task in Alzheimer disease
P. S. Boggio et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2009)
Glycine Site of NMDA Receptor Serves as a Spatiotemporal Detector of Synaptic Activity Patterns
Yan Li et al.
JOURNAL OF NEUROPHYSIOLOGY (2009)
A Novel Nicotinic Acetylcholine Receptor Subtype in Basal Forebrain Cholinergic Neurons with High Sensitivity to Amyloid Peptides
Qiang Liu et al.
JOURNAL OF NEUROSCIENCE (2009)
Amyloid β-Induced Neuronal Hyperexcitability Triggers Progressive Epilepsy
Rimante Minkeviciene et al.
JOURNAL OF NEUROSCIENCE (2009)
Amyloid-β as a positive endogenous regulator of release probability at hippocampal synapses
Efrat Abramov et al.
NATURE NEUROSCIENCE (2009)
A novel GSK-3 beta inhibitor reduces Alzheimer's pathology and rescues neuronal loss in vivo
L. Sereno et al.
NEUROBIOLOGY OF DISEASE (2009)
Oligomeric amyloid β associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques
Robert M. Koffie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Diminished perisomatic GABAergic terminals on cortical neurons adjacent to amyloid plaques
Virginia Garcia-Marin et al.
FRONTIERS IN NEUROANATOMY (2009)
Glycogen synthase kinase-3β, or a link between amyloid and tau pathology?
D. Muyllaert et al.
GENES BRAIN AND BEHAVIOR (2008)
Valproic acid inhibits Aβ production, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse models
Hong Qing et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer's disease
Rene O. Sanchez-Mejia et al.
NATURE NEUROSCIENCE (2008)
Loss of VGLUT1 and VGLUT2 in the prefrontal cortex is correlated with cognitive decline in Alzheimer disease
Alireza Kashani et al.
NEUROBIOLOGY OF AGING (2008)
Transcranial direct current stimulation improves recognition memory in Alzheimer disease
R. Ferrucci et al.
NEUROLOGY (2008)
Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease
Marc Aurel Busche et al.
SCIENCE (2008)
E/I balance and GABAA receptor plasticity
Jean-Marc Fritschy
Frontiers in Molecular Neuroscience (2008)
The GSK3 hypothesis of Alzheimer's disease
Claudie Hooper et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Intranasal insulin improves cognition and modulates β-amyloid in early AD
M. A. Reger et al.
NEUROLOGY (2008)
Increased fMRI responses during encoding in mild cognitive impairment
Anne Hämäläinen et al.
NEUROBIOLOGY OF AGING (2007)
Valsartan lowers brain β-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease
Jun Wang et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease
Jorge J. Palop et al.
NEURON (2007)
Pathological tau tangles localize to focal cortical dysplasia in older patients
Arjune Sen et al.
EPILEPSIA (2007)
Reducing endogenous tau ameliorates amyloid β-induced deficits in an Alzheimer's disease mouse model
Erik D. Roberson et al.
SCIENCE (2007)
Targeting soluble Aβ peptide with Tramiprosate for the treatment of brain amyloidosis
Francine Gervais et al.
NEUROBIOLOGY OF AGING (2007)
UP inhibits LTD in the hippocampus via regulation of GSK3β
Stephane Peineau et al.
NEURON (2007)
Neuroprotective effects of regulators of the glycogen synthase kinase-3β signaling pathway in a transgenic model of Alzheimer's disease are associated with reduced amyloid precursor protein phosphorylation
Edward Rockenstein et al.
JOURNAL OF NEUROSCIENCE (2007)
Neurocognitive aging: prior memories hinder new hippocampal encoding
Iain A. Wilson et al.
TRENDS IN NEUROSCIENCES (2006)
Alterations in memory networks in mild cognitive impairment and Alzheimer's disease: An independent component analysis
Kim A. Celone et al.
JOURNAL OF NEUROSCIENCE (2006)
High-frequency intracerebral EEG activity (100-500 Hz) following interictal spikes
Elena Urrestarazu et al.
EPILEPSIA (2006)
Magnetoencephalographic evaluation of resting-state functional connectivity in Alzheimer's disease
C. J. Stam et al.
NEUROIMAGE (2006)
Involvement of I2PP2A in the abnormal hyperphosphorylation of tau and its reversal by Memantine
Muhammad Omar Chohan et al.
FEBS LETTERS (2006)
Tau phosphorylation and aggregation in Alzheimer's disease pathology
J Avila
FEBS LETTERS (2006)
Familial risk for Alzheimer's disease alters fMRI activation patterns
SS Bassett et al.
BRAIN (2006)
Incidence and predictors of seizures in patients with Alzheimer's disease
JC Amatniek et al.
EPILEPSIA (2006)
Lipopolysaccharide-induced microglial activation induces learning and memory deficits without neuronal cell death in rats
S Tanaka et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2006)
Safety of rTMS to non-motor cortical areas in healthy participants and patients
K Machii et al.
CLINICAL NEUROPHYSIOLOGY (2006)
Medial temporal lobe neuromagnetic hypoactivation and risk for developing cognitive decline in elderly population: A 2-year follow-up study
F Maestu et al.
NEUROBIOLOGY OF AGING (2006)
Chronic lithium treatment decreases tau lesions by promoting ubiquitination in a mouse model of tauopathies
H Nakashima et al.
ACTA NEUROPATHOLOGICA (2005)
Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD
BC Dickerson et al.
NEUROLOGY (2005)
Regulation of NMDA receptor trafficking by amyloid-β
EM Snyder et al.
NATURE NEUROSCIENCE (2005)
fMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease
MW Bondi et al.
NEUROLOGY (2005)
Theta burst stimulation of the human motor cortex
YZ Huang et al.
NEURON (2005)
EEG dynamics in patients with Alzheimer's disease
JS Jeong
CLINICAL NEUROPHYSIOLOGY (2004)
Receptor trafficking and synaptic plasticity
GL Collingridge et al.
NATURE REVIEWS NEUROSCIENCE (2004)
SGS742:: the first GABAB receptor antagonist in clinical trials
W Froestl et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Learning modulation by endogenous hippocampal IL-1: Blockade of endogenous IL-1 facilitates memory formation
AM Depino et al.
HIPPOCAMPUS (2004)
The Mood-Stabilizing Agent Valproate Inhibits the Activity of Glycogen Synthase Kinase-3
Guang Chen et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Sedation caused by primidone may exacerbate dementia
HJ Koch et al.
EPILEPSY & BEHAVIOR (2003)
Alzheimer's disease as a disconnection syndrome?
X Delbeuck et al.
NEUROPSYCHOLOGY REVIEW (2003)
GSK-3α regulates production of Alzheimer's disease amyloid-β peptides
CJ Phiel et al.
NATURE (2003)
Aβ toxicity in Alzheimer's disease:: globular oligomers (ADDLs) as new vaccine and drug targets
WL Klein
NEUROCHEMISTRY INTERNATIONAL (2002)
Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo
DM Walsh et al.
NATURE (2002)
Interleukin-1, neuroinflammation, and Alzheimer's disease
RE Mrak et al.
NEUROBIOLOGY OF AGING (2001)
Site-directed antisense oligonucleotide decreases the expression of amyloid precursor protein and reverses deficits in learning and memory in aged SAMP8 mice
VB Kumar et al.
PEPTIDES (2000)
Interleukin-1 and the immunogenetics of Alzheimer disease
RE Mrak et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2000)
D-β-hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease
Y Kashiwaya et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
